Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells.

PloS one - 1 Jan 2014

Zhang Peng, Yi Shuhong, Li Xi, Liu Ruilei, Jiang Hua, Huang Zenan, Liu Yu, Wu Juekun, Huang Yong

Abstract excerpt

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) in human immune system. DC-based tumor vaccine has met with some success in specific malignancies, inclusive of breast cancer. In this study, we electrofused MDA-MB-231 breast cancer cell line with day-3 DCs derived from peripheral blood monocytes, and explored the biological characteristics of fusion vaccine and its anti-tumor effects in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Vaccines
Share to Cell Fusion
Share to Coculture Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dendritic Cells

Share to Electricity

Share to Immunotherapy, Adoptive

Share to Interleukin-12

Share to Triple Negative Breast Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 25036145
DOI: 10.1371/journal.pone.0102197
PMCID: PMC4103844

Genes

TNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells.PMID 25036145Read ↗

Dendritic cells fused with allogeneic breast cancer cell line induce tumor antigen-specific CTL responses against autologous breast cancer cells.Semantic proximity Read ↗

Dendritic-Tumor Fusion Cell-Based Cancer VaccinesSemantic proximity Read ↗

Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.Semantic proximity Read ↗

Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined TherapiesSemantic proximity Read ↗

Genetically Engineered Cytomembrane Nanovaccines for Cancer ImmunotherapySemantic proximity Read ↗

Cytomembrane nanovaccines show therapeutic effects by mimicking tumor cells and antigen presenting cellsSemantic proximity Read ↗

Hybrids of Dendritic Cells and Tumor Cells Generated by Electrofusion Simultaneously Present Immunodominant Epitopes from Multiple Human Tumor-Associated Antigens in the Context of MHC Class I and Class II MoleculesSemantic proximity Read ↗

Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo.Semantic proximity Read ↗

Equipping Cancer Cell Membrane Vesicles with Functional DNA as a Targeted Vaccine for Cancer ImmunotherapySemantic proximity Read ↗

Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine.Semantic proximity Read ↗

Different In Vitro-Generated MUTZ-3-Derived Dendritic Cell Types Secrete Dexosomes with Distinct Phenotypes and Antigen Presentation Potencies.Semantic proximity Read ↗

Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.